🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well olaparib and ceralasertib (AZD6738) wo...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-01-30
Trial ID
NCT03878095
This biomarker study has been designed to assess the effects of different a...
Status
Completed
Location
Research Site
Start Date
2017-09-18
Trial ID
NCT03022409
Treatments Being Tested
This phase II trial studies how well ceralasertib, am Ataxia telangiectasia...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2019-01-17
Trial ID
NCT03682289
Treatments Being Tested
Aim of this phase 2 study is to explore the safety and efficacy of thoracic...
Status
Recruiting
Location
ASST degli Spedali Civili di Brescia
Start Date
2025-08-07
Trial ID
NCT06680050
Treatments Being Tested
This phase II study assesses the efficacy of the combination of olaparib wi...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2018-12-12
Trial ID
NCT03801369
Treatments Being Tested
This is a modular, phase I/ phase 1 b, open-label, multicentre study of cer...
Status
Active Not Recruiting
Location
Research Site
Start Date
2014-10-31
Trial ID
NCT02264678
Treatments Being Tested
This is an open-label, multi-centre, umbrella Phase II study in participant...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-12-18
Trial ID
NCT03334617
Treatments Being Tested
This study is a phase II study of AZD6738 in combination with durvalumab in...
Status
Unknown
Location
Samsung Medical Center
Start Date
2019-07-30
Trial ID
NCT03780608
Treatments Being Tested
This study is to assess the efficacy and safety of olaparib monotherapy ver...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-03-07
Trial ID
NCT03330847
This is an open-label, two-part study in participants with NSCLC, ovarian c...
Status
Not Yet Recruiting
Location
Research Site
Start Date
2025-01-17
Trial ID
NCT06754761
Treatments Being Tested